A. Bauernfeind et al., A NOVEL CLASS-C BETA-LACTAMASE (FOX-2) IN ESCHERICHIA-COLI CONFERRINGRESISTANCE TO CEPHAMYCINS, Antimicrobial agents and chemotherapy, 41(9), 1997, pp. 2041-2046
An Escherichia coli strain resistant to a broad spectrum of beta-lacta
ms, including cephamycins, was isolated from a patient suffering from
urinary tract infection. A resistance plasmid (pRjlVP-7) was transferr
ed from the clinical isolate to an Escherichia coli recipient. Both st
rains Produce a cefoxitin-hydrolyzing beta-lactamase focusing at pi 6.
7. The phenotype was similar to that of a Klebsiella pneumoniae strain
producing cephamycinase FOX-1, so primers were selected from the FOX-
1 sequence to amplify the bla gene of the transconjugant. The PCR prod
uct obtained was sequenced: The percentage of identity of the deduced
aminoacid sequence with sequences of other AmpC-type beta-lactamases w
as 96.9% with FOX-1, 74.9% with CMY-1, and 67.7% with MOX-1. This new
plasmid-mediated enzyme is most closely related to FOX-1 (11 amino aci
d exchanges). We therefore propose the designation FOX-2.